Literature DB >> 9218287

Rabies and rabies research: past, present and future.

Z F Fu1.   

Abstract

Rabies is probably the oldest recorded infection of mankind. The development of the first rabies vaccine by Pasteur surely had been hoped to eliminate or at least drastically reduce its incidence. However, this goal has not been achieved because rabies is maintained in many animal reservoirs, including both domestic and wild. There are still many aspects of the pathogenicity of rabies that are unknown. For example, we have no explanation for the long incubation period (up to 6 years). Furthermore, new patterns of rabies infection present a problem for epidemiologists and virologists alike. There are several cases of human rabies in which there was no history of a bite. Despite these continuing problems, there has been tremendous progress in the control of rabies. Cheap and safe vaccines for animals as well as humans have been developed. Oral vaccination of wildlife with recombinant rabies virus vaccines is beginning to reduce the incidence of rabies among foxes and raccoons. Vaccination of stray dogs could lead to the eradication of rabies in countries where dog rabies is the sole source of human exposure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9218287     DOI: 10.1016/s0264-410x(96)00312-x

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  32 in total

1.  Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.

Authors:  Jinying Ge; Xijun Wang; Lihong Tao; Zhiyuan Wen; Na Feng; Songtao Yang; Xianzhu Xia; Chinglai Yang; Hualan Chen; Zhigao Bu
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Genetic characterisation of rabies virus isolates in Bosnia and Herzegovina.

Authors:  Ramiz Velić; Tarik Bajrović; Sukrija Zvizdić; Lejla Velić; Sadeta Hamzić
Journal:  Bosn J Basic Med Sci       Date:  2008-08       Impact factor: 3.363

3.  Rescue of a wild-type rabies virus from cloned cDNA and assessment of the proliferative capacity of recombinant viruses.

Authors:  Qin Tian; Yifei Wang; Qiong Zhang; Jun Luo; Mingzhu Mei; Yongwen Luo; Xiaofeng Guo
Journal:  Virus Genes       Date:  2017-04-26       Impact factor: 2.332

4.  Expression of MIP-1alpha (CCL3) by a recombinant rabies virus enhances its immunogenicity by inducing innate immunity and recruiting dendritic cells and B cells.

Authors:  Ling Zhao; Harufusa Toriumi; Hualei Wang; Yi Kuang; Xiaofeng Guo; Kinjiro Morimoto; Zhen F Fu
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

5.  Expression of neuronal CXCL10 induced by rabies virus infection initiates infiltration of inflammatory cells, production of chemokines and cytokines, and enhancement of blood-brain barrier permeability.

Authors:  Qingqing Chai; Ruiping She; Ying Huang; Zhen F Fu
Journal:  J Virol       Date:  2014-10-22       Impact factor: 5.103

6.  Attenuated rabies virus activates, while pathogenic rabies virus evades, the host innate immune responses in the central nervous system.

Authors:  Zhi W Wang; Luciana Sarmento; Yuhuan Wang; Xia-qing Li; Vikas Dhingra; Tesfai Tseggai; Baoming Jiang; Zhen F Fu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination.

Authors:  Yongjun Wen; Hualei Wang; Hua Wu; Fuhe Yang; Ralph A Tripp; Robert J Hogan; Zhen F Fu
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

8.  Relaxation of purifying selection on the SAD lineage of live attenuated oral vaccines for rabies virus.

Authors:  Austin L Hughes
Journal:  Infect Genet Evol       Date:  2009-05-04       Impact factor: 3.342

Review 9.  Rabies in small animals.

Authors:  Sarah N Lackay; Yi Kuang; Zhen F Fu
Journal:  Vet Clin North Am Small Anim Pract       Date:  2008-07       Impact factor: 2.093

10.  Immune evasion by rabies viruses through the maintenance of blood-brain barrier integrity.

Authors:  Anirban Roy; D Craig Hooper
Journal:  J Neurovirol       Date:  2008-11-18       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.